Insider · CIK 0002106781
Neil William Aubuchon
Files at VKTX (Viking Therapeutics, Inc.). First filing Mar 10, 2026, latest Mar 10, 2026.
Neil William Aubuchon files SEC Form 4 as officer at VKTX (Viking Therapeutics, Inc.). Since Mar 10, 2026, Neil William Aubuchon has reported 1 open-market buy worth $150k and 0 open-market sells worth $0, the latest filed on Mar 10, 2026.
A track record needs three past buys with six months of prices behind them; Neil William Aubuchon has 0, so none is measured yet.
The newest scored trade: bought $150k of VKTX on Mar 10, 2026, filed Mar 10, 2026, scored 38 (weak). In the last 12 months: 1 buy worth $150k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VKTX: Viking Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | VKTXbuy Viking Therapeutics, Inc. | $150k 4,475 shares | - | +73% from low-18% from high |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | VKTX Viking Therapeutics, Inc. | POpen-market purchase Common Stock, par value $0.00001 per share | +4,475 | $33.50 | $150k | 4,475 | Mar 10, 2026 |
| Jan 12, 2026 | VKTX Viking Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +180,000 | $0.00 | $0 | 180,000 | Jan 26, 2026 |
Questions about Neil William Aubuchon
Answered from the filings on this page, as of the latest one.
Is Neil William Aubuchon buying or selling?
In the last 12 months Neil William Aubuchon reported 1 open-market buy worth $150k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $150k of VKTX on Mar 10, 2026. Grants, option exercises and tax withholding are not counted.
How did Neil William Aubuchon's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Neil William Aubuchon has 0.
Where does Neil William Aubuchon file Form 4?
Neil William Aubuchon has filed Form 4 at VKTX (Viking Therapeutics, Inc.) as Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.